Keap1âNrf2 pathway: A promising target towards lung cancer prevention and therapeutics
Objectives: Drugs for targeted therapy have become a new strategy of adjuvant therapy for treatment of lung cancer. The Keap1 (kelch-like ECH-associated protein 1)âNrf2 (nuclear factor erythroid 2-related factor 2) pathway is recognized to be critical in regulating genes related to the cellular prot...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
KeAi Communications Co., Ltd.
2015
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/eeda3216f74f4415abf1daac22219248 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|